Early Surgical Intervention in Parkinson’s Disease: Why Waiting Too Long May Limit Treatment Benefits? – Dr. Naren Nayak

Thane (Maharashtra) [India], February 24: Patients with Parkinson’s disease require primary medication for their condition until they reach the point where doctors need to conduct surgery. Medical research currently demonstrates that patients with Parkinson’s disease can achieve better long-term results through surgical treatment when they undergo surgery at an early stage of their condition.

Dr. Naren Nayak, Consultant Neurosurgeon in Thane and Movement Disorder Specialist, states that patients who postpone their medical evaluation until their symptoms become severe will experience lower treatment success with advanced medical solutions which will hinder their progress toward better health. Parkinson’s disease causes patients to develop their condition in stages which results in medications producing “on-off” effects and multiple “on” and “off” symptom periods. People hold a false belief which Dr. Nayak describes as surgical treatment needing to wait until all other methods have shown no success. The early assessment process enables specialists to identify patients who will receive the most benefit from surgical procedures such as Deep Brain Stimulation (DBS) for Parkinson’s disease before their condition reaches a point which will result in less effective outcomes. Parkinson’s disease DBS treatment operates as an established surgical procedure which scientists have researched through medical studies. The treatment enables patients to control their tremors and rigidity along with their movement speed and motor fluctuations by using electrical stimulation to activate brain areas.

DBS proves effective when provided at correct times because it decreases medication requirements while sustaining daily symptom control and enabling substantial progress in patient independence. Early surgical assessment leads to two outcomes for patients which include assessment of their medical condition through neurological testing and neurosurgical evaluation for determining which treatments should proceed and when based on their medical condition. Modern functional neurosurgery provides patients with targeted treatment options which include DBS, Thalamotomy, Pallidotomy, Radiofrequency Lesioning and MR-Guided Focused Ultrasound (MRgFUS) for specifically selected patients who require movement disorder treatment. The implementation of advanced imaging systems together with precise targeting abilities and modern technological advancements enables procedures to achieve improved safety levels and enhanced operational efficiency compared to previous times.

Research from around the world shows that patients who get surgery in the early stages of their medical condition experience better results with their motor skills and overall life satisfaction while maintaining higher levels of social and work engagement. The healthcare system needs to draw more attention toward treating disability which happens before patients reach critical impairment because this period provides major advantages which include surgical treatment with higher success rates. Dr. Nayak emphasizes that timely referral is critical, stating that “patients should be evaluated for surgical options when medications start causing side effects or no longer provide consistent control, not years later when options become restricted.”

Dr. Naren Nayak

Phone: +91 9820456326

KIMS Hospitals, Thane, Thane Hiranandani Estate Queens Street, Ghodbunder Rd, opposite BRENTFORD, Patlipada, Thane West, Thane, Maharashtra 400607

Website: https://drnarennayak.com/

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

chandan healthcare diagnostics franchise network Health healthcare business NABH NABL NSE Emerge pathology radiology

Chandan Healthcare Scales Franchise Network to 500+ Franchises; Targets 1,000 Franchises by FY27-End

Lucknow (Uttar Pradesh) [India], September 23: Chandan Healthcare Limited (NSE – CHANDAN), – an integrated diagnostics company offering pathology and radiology services, has expanded its diagnostic franchise network to 568 franchises within a short span of six months, strengthening its last-mile presence and diagnostic collection network. The Company plans to scale the network to 1,000 […]

Read More
AI healthcare breast cancer screening c-met cdsco clinical trials fda Health lord’s mark medical device thermal imaging

Lord’s Mark Industries Gets Nod for Final Clinical Trials of AI Breast Cancer Screening Device

New Delhi [India], September 23: Lord’s Mark Industries Limited has informed the BSE that its Technical Committee has approved the final clinical trial stage for its AI-powered, radiation-free wearable breast cancer screening device, with trials planned across the USA, Great Britain and Europe. The disclosure was made under Regulation 30 of the SEBI Listing Obligations […]

Read More
abbit dental disease cbct ct imaging gi stasis Health malocclusion pet care rabbit care rabbit health veterinary dentistry

When Rabbits Stop Eating: Looking Beyond the Teeth – The Emerging Role of Cone Beam CT in Rabbit Dental Disease

New Delhi [India], September 21: Rabbits have become increasingly popular companion animals over the last decade, thanks to their gentle temperament, intelligence and affectionate nature. Despite their growing popularity, rabbit health is often misunderstood, particularly when it comes to dental disease. Many owners assume that a rabbit refusing food is suffering from a digestive problem […]

Read More